MRE11 and colorectal carcinoma: Here, we provided evidence that the targeting of either MRE11 or RAD51 sensitizes primary CRC-SCs to the CHK1 inhibitor prexasertib by inducing a mitotic catastrophe process culminating in caspase-dependent cell death.